Chemotherapy for the biliary tract cancers: moving toward improved survival time. - Wikidata - wikimedia - TriplyDB

Chemotherapy for the biliary tract cancers: moving toward improved survival time.

Chemotherapy for the biliary tract cancers: moving toward improved survival time.

http://www.wikidata.org/entity/Q37983498

about

Administration of Gemcitabine for Metastatic Adenocarcinoma during Pregnancy: A Case Report and Review of the Literature Transcatheter arterial chemoembolization with gemcitabine and oxaliplatin for the treatment of advanced biliary tract cancer.YAP is a critical oncogene in human cholangiocarcinoma Management of combined hepatocellular-cholangiocarcinoma: a case report and literature review Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design.Chemotherapy for cholangiocarcinoma: An update.EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma.Recent advances for the treatment of pancreatic and biliary tract cancer after first-line treatment failure.Surgical treatment of gallbladder carcinoma: a critical review.Cholangiocellular Carcinoma.KRAS Mutation as a Potential Prognostic Biomarker of Biliary Tract Cancers.Port-Site Resection in Surgical Management of Incidental Gallbladder Cancer: A Still Unresolved Question.N-myc downstream-regulated gene 2 inhibits human cholangiocarcinoma progression and is regulated by leukemia inhibitory factor/MicroRNA-181c negative feedback pathway.Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.

P2860

Q33832239-DB767125-0E96-449B-9762-27B1185D73C2 Q35179917-C25BE53B-B8CB-4E72-B3E2-B540F3490C99 Q36232005-72950A83-0A45-4DFF-ADEF-4796BC1EFA78 Q36498935-7397BFFE-CC00-476A-A3C5-15F9A0CF6057 Q37017110-F065B553-4E3F-4732-A306-42A1F554A13A Q37064558-2183FDFF-E21E-4E20-9FB2-2AEE2101D76A Q37215717-F068D28F-F4BD-4B98-B2BC-7B3D6607FAB3 Q38577917-137DAAEC-AE94-4532-983D-BB761B06F579 Q38632029-BA4C6459-4899-4FF0-BF3A-5799F3FCEDE8 Q38746546-3270EEA6-A956-4A76-9D79-B86053674137 Q39070009-78146D8D-7A23-4401-8A90-AE8CE5E005BD Q49843666-B9C586F9-61E4-40EF-A758-3C1B44ADA4B1 Q51566647-3458574D-59AF-472B-BE05-C4969811DE74 Q53090136-04DB71E1-014B-4211-A692-59B7D0F8147C

P2860

Chemotherapy for the biliary tract cancers: moving toward improved survival time.

http://www.wikidata.org/entity/Q37983498

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Chemotherapy for the biliary tract cancers: moving toward improved survival time.

@en

Chemotherapy for the biliary tract cancers: moving toward improved survival time.

@nl

type

label

Chemotherapy for the biliary tract cancers: moving toward improved survival time.

@en

Chemotherapy for the biliary tract cancers: moving toward improved survival time.

@nl

prefLabel

Chemotherapy for the biliary tract cancers: moving toward improved survival time.

@en

Chemotherapy for the biliary tract cancers: moving toward improved survival time.

@nl

P1433

Q37983498-0734824F-1D3F-4C45-8502-5267CDF205C7

P1476

Q37983498-42753715-987F-4764-BF26-772F87BEFFAD

P2093

Q37983498-12A500CA-C6F2-473C-9383-3115B777A6D1

Q37983498-200A256B-5DA0-48CD-92D8-858FC48BDC5D

Q37983498-3CF5F246-E4E4-45E8-8A08-122078FDC722

Q37983498-3EE9BD84-460A-4145-96B5-DB7370E570C9

Q37983498-D39A2D69-30E9-47A9-BC4C-984BAE74B84D

Q37983498-E7C791DF-B593-4198-9DD8-9A4FDE3639D9

P2860

Q37983498-0028B656-4D8E-44DD-B70B-774725BD789D

Q37983498-0066556B-D95A-47C5-B305-52AC16ABFA70

Q37983498-00E1CA61-CD05-4CC2-8F29-AAEFE471D6BC

Q37983498-0736DA57-DC18-4060-B9FE-781A5F0F795E

Q37983498-09612124-85D2-4E44-BED3-E783107329A4

Q37983498-09A3AC71-B5F7-42B5-BF55-2DB28650A3D7

Q37983498-0EE01210-8DE9-42E9-9D65-499F160BDD20

Q37983498-106E6ED2-CE87-4519-BFE9-83FDACF6B518

Q37983498-107C6A6F-4B2B-40D6-AC79-6F6937D97794

Q37983498-152D6FAA-8DA6-40B4-82CC-2F69952501F8

P2888

Q37983498-EE3E16CF-84A1-4E4F-824A-0BC0CD6A2A08

P304

Q37983498-7C6DD0EA-8D43-4FBC-BDEE-411322207A74

P31

Q37983498-280D186C-6A5C-4E03-9201-B77963767728

P356

Q37983498-11A49830-2AC7-4DA9-8909-077D0AA1295C

P433

Q37983498-E022ECF0-1E2B-4329-AB83-87BBFC68945B

P478

Q37983498-5D93206E-DCA0-4860-AFA7-7E642FA44838

P50

Q37983498-3B286610-1A6B-4D71-A8F2-8FB8550F67F3

Q37983498-EFA517F3-E1C9-4765-BC45-6E226872A1AF

P577

Q37983498-E6FA2799-E76F-40A7-B692-8D552B83AA1D

P698

Q37983498-3781B388-8CBB-4BF7-B2C6-4CB02EB02A01

P921

Q37983498-43EA54A8-D1FD-44F2-9182-C8AD71B5A58F

P356

S12029-012-9369-2

P1433

Journal of gastrointestinal cancer

P1476

Chemotherapy for the biliary tract cancers: moving toward improved survival time.

@en

P2093

Adriana Romiti

http://www.w3.org/2001/XMLSchema#string

Chiara D'Antonio

http://www.w3.org/2001/XMLSchema#string

Ida Sarcina

http://www.w3.org/2001/XMLSchema#string

Roberta Di Rocco

http://www.w3.org/2001/XMLSchema#string

Valeria Durante

http://www.w3.org/2001/XMLSchema#string

Viola Barucca

http://www.w3.org/2001/XMLSchema#string

P2860

Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system

Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival

Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials

The number of metastatic lymph nodes in extrahepatic bile duct carcinoma as a prognostic factor.

Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer.

Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma.

A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma

Mitomycin C with weekly 24-h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract and periampullar carcinomas.

P2888

s12029-012-9369-2

P304

396-404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12029-012-9369-2

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

Paolo Marchetti

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22328060

http://www.w3.org/2001/XMLSchema#string

P921